title: Phase II multicentre study of the nitrosourea fotemustine in inoperable squamous cell lung carcinoma.
authors.affiliation: Institut Gustave Roussy, Villejuif, France.
authors.forename: T
authors.initials: T
authors.lastname: Le Chevalier
authors.forename: C
authors.initials: C
authors.lastname: Zabbe
authors.forename: S
authors.initials: S
authors.lastname: Gouva
authors.forename: M L
authors.initials: ML
authors.lastname: Cerrina
authors.forename: E
authors.initials: E
authors.lastname: Quoix
authors.forename: A
authors.initials: A
authors.lastname: Riviere
authors.forename: P
authors.initials: P
authors.lastname: Berthaud
authors.forename: C
authors.initials: C
authors.lastname: Prache
authors.forename: J
authors.initials: J
authors.lastname: Berille
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D009607:Nitrosourea Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D009943:Organophosphorus Compounds / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D009943:Organophosphorus Compounds; C054368:fotemustine